Kowa Optimed
Torrance, CA- Kowa Optimed Inc., who is part of a multi faceted global company providing products and services to diverse markets, recently announced that they have received 510(k) approval from the U.S. Food and Drug Administration (FDA) for the marketing of their latest model, the VX-20 retinal camera.
Like the VX-10, the VX-20 offers non-mydriatic, mydriatic, and FA modes with 50° and 30° views. Additionally the VX-20 has an autofluorescence mode to provide further diagnostic investigation of the health of the retina such as AMD. Linked to VK-2 software the VX-20 provides outstanding options for fundus image analysis. With the built in PC and high resolution camera back, this fundus camera is a versatile diagnostic tool with stand-alone capability.
Kowa VX-20 Options and Features:
- VK-2
The optional VK-2 high performance and digital imaging software allows for enhanced viewing and image manipulation for further diagnostic investigation. - Built in PC
The VX-20 features a built in PC with a high- resolution camera back. Its easy to use controls were specifically designed to be intuitively operational, even in a dark exam room. - DigiVersal
Digiversal software automatically converges patient image files from multiple pieces of diagnostic equipment into a single file on a single screen. This software solution makes image organization and comparison seamless and easy, allowing you to focus on patient care and growing your practice.
About Kowa Optimed, Inc:
Kowa Optimed is part of Kowa Company limited founded in 1894 which has achieved becoming one of the largest privately owned companies in Japan. The group has four primary divisions among which ethical and OTC pharmaceutical products, optics and medical devices play a large role with research and development facilities, factories and sales offices across Japan and subsidiaries across the globe. Kowa Optimed is part of the Electronics and Optics Division of the company. Since its inception in 1946, the Kowa Electronics and Optics Division have combined electronics, mechanical design and optics to create a wide range of significant new technologies. Since the launch of its first retinal camera in 1962, Kowa has been devoted to producing the most innovative optical products and integrated technology solutions in the world. The company’s focus on leading edge technology, flexible machine technology, application software and traditional optical technology has produced a wide range of products designed to enhance the visual experience and provide vision solutions and diagnostics for all users.
For information contact
Kowa Optimed, Inc 20001 S.
Vermont Avenue, Torrance, CA 90502,
Phone: (800) 966-5692
or visit http://www.kowa-usa.com/eyecare/ and click on the new products.
Contact Information:
Dan Meyers BrandDNAinc
[email protected]
(310) 260-5623